Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.
Ovarian cancer is the fifth leading cause of cancer death in women. Ovarian cancers display a high degree of complex genetic alterations involving many oncogenes and tumor suppressor genes. Analysis of the association between genetic alterations and clinical endpoints such as survival will lead to i...
Main Authors: | David A Engler, Sumeet Gupta, Whitfield B Growdon, Ronny I Drapkin, Mai Nitta, Petra A Sergent, Serena F Allred, Jenny Gross, Michael T Deavers, Wen-Lin Kuo, Beth Y Karlan, Bo R Rueda, Sandra Orsulic, David M Gershenson, Michael J Birrer, Joe W Gray, Gayatry Mohapatra |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3280266?pdf=render |
Similar Items
-
Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
by: Christopher K McCann, et al.
Published: (2011-01-01) -
Focal Serous Tubal Intra-Epithelial Carcinoma Lesions Are Associated With Global Changes in the Fallopian Tube Epithelia and Stroma
by: Jingni Wu, et al.
Published: (2022-03-01) -
Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression
by: Michael T. Richardson, et al.
Published: (2022-12-01) -
Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum
by: David M. Gershenson, et al.
Published: (2020-11-01) -
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
by: Sho Sato, et al.
Published: (2023-01-01)